Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 3, 2022Experimental and Therapeutic MedicineOpen Access

Prevalence and treatment of venous thromboembolism in patients with solid tumors

View Full Paper
Ask AI
Bookmark
Share

Why the study?

Cancer-associated venous thromboembolism is rising in incidence, but research focusing on it and current anticoagulation therapy strategies remains limited.

Population

4,926 patients with major solid tumors at a hospital in China

Design

Retrospective medical record review

Follow-up

1 year for patients receiving anticoagulation therapy

Authors

HZHuihan ZhaoFLFangfang LiangYLYing Ling

Discussion

Loading...

Member takes

Overview

Hypertension and advanced stage associate with VTE in solid-tumor inpatients; hypothesis-generating for risk stratification, needs prospective validation.

Structured PICO

P
Population
4,926 hospitalized adults (aged ≥18 years) with major solid tumors (primary lung, ovarian, breast, gastric, colorectal, cervical, or pancreatic cancer), mean age 55.86, 40.9% male, based in China.
O
Outcome
Prevalence of cancer-associated venous thromboembolism (VTE)

Cancer-associated VTE occurs in 2.4% of hospitalized solid tumor patients, with hypertension and advanced cancer stage as independent risk factors, and adherence to long-term anticoagulation remains inadequate.

Limitations

  • Single medical center
  • Retrospective nature leading to possible missed screening and underdiagnosis
  • Prevalence not analyzed in relation to different chemotherapy regimens
  • VTE recurrence not measured due to 1-year follow-up limit

Cite This Study

Zhao et al. (2022) studied this question.

synapsesocial.com/papers/6a22ea454cc0f16e7ccabdbchttps://doi.org/10.3892/etm.2022.11679
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Cancer and Venous Thromboembolic Disease: A Review2017 · 254 citations
  2. 2Cancer-Associated Venous Thromboembolism in the Real World ― From the COMMAND VTE Registry ―2019 · 91 citations
  3. 3Rate of venous thromboembolism and atrial fibrillation in a real-world case series of advanced cancer patients: the CaTEV Study2020 · 4 citations
  4. 4Treatment of cancer-associated venous thromboembolism in the age of direct oral anticoagulants2019 · 112 citations
  5. 5The risk of venous thromboembolism in cancer patients receiving chemotherapy: a meta-analysis with systematic review2021 · 10 citations